Effects of δ9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress

Journal of Psychopharmacology

Volumn 24, Issue 5, 2010, Pages 767-777

  Fokos, S ^a   Panagis, G ^a  

^a School of Social Sciences   (Greece)

Author keywords

Anxiety; Cannabinoid; Chronic unpredictable stress; Elevated plus maze; Intracranial self stimulation; Reward

Indexed keywords

DRONABINOL; ANXIOLYTIC AGENT; PSYCHOTROPIC AGENT; TETRAHYDROCANNABINOL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL HOUSING; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN FUNCTION; CHRONIC STRESS; COLD STRESS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FORCED SWIMMING TEST; IMMOBILIZATION STRESS; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; SELF STIMULATION; TRANQUILIZING ACTIVITY; WEIGHT GAIN; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTRODE; ELECTROSTIMULATION; EXPLORATORY BEHAVIOR; MENTAL STRESS; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BODY WEIGHT; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; EXPLORATORY BEHAVIOR; MALE; PSYCHOTROPIC DRUGS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SELF STIMULATION; STRESS, PSYCHOLOGICAL; TETRAHYDROCANNABINOL;

EID: 77952216053     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109104904     Document Type: Article

References (74)

1. Adams, IB, Martin, BR (1996) Cannabis: pharmacology and toxicology in animals and humans. Addiction 91: 1585-1614.
2. Arevalo, C., de Miguel, R., Hernandez-Tristan, R. (2001) Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacol Biochem Behav 70: 123-131.
3. Arnold, JC, Hunt, GE, McGregor, IS (2001) Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats. Life Sci 70: 97-108.
4. Banasr, M., Valentine, GW, Li, XY, Gourley, SL, Taylor, JR, Duman, RS (2007) Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry 62: 496-504.
5. Berrendero, F., Maldonado, R. (2002) Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 163: 111-117.
6. Bortolato, M., Campolongo, P., Mangieri, RA, Scattoni, ML, Frau, R., Trezza, V., et al. (2006) Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31: 2652-2659.
7. Bortolato, M., Mangieri, RA, Fu, J., Kim, JH, Arguello, O., Duranti, A., et al. (2007) Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry 62: 1103-1110.
8. Braida, D., Limonta, V., Malabarba, L., Zani, A., Sala, M. (2007) 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats. Eur J Pharmacol 555: 156-163.
9. Campbell, KA, Evans, G., Gallistel, CR (1985) A microcomputer-based method for physiologically interpretable measurement of the rewarding efficacy of brain stimulation. Physiol Behav 35: 395-403.
10. Coulombe, D., Miliaressis, E. (1987) Fitting intracranial self-stimulation data with growth models. Behav Neurosci 101: 209-214.
11. Cruz, FC, Quadros, IM da SPC, Miczek, KA (2008) Maternal separation stress in male mice: long-term increases in alcohol intake. Psychopharmacology (Berl) 201: 459-468.
12. DgAquila, PS, Brain, P., Willner, P. (1994) Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol Behav 56: 861-867.
13. DgAquila, PS, Newton, J., Willner, P. (1997) Diurnal variation in the effect of chronic mild stress on sucrose intake and preference. Physiol Behav 62: 421-426.
14. Edmonds, DE, Gallistel, CR (1974) Parametric analysis of brain stimulation reward in the rat: III. Effect of performance variables on the reward summation function. J Comp Physiol Psychol 87: 876-883.
15. Forbes, NF, Stewart, CA, Matthews, K., Reid, IC (1996) Chronic mild stress and sucrose consumption: validity as a model of depression. Physiol Behav 60: 1481-1484.
16. Gardner, EL, Paredes, W., Smith, D., Donner, A., Milling, C., Cohen, D., et al. (1988) Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol. Psychopharmacology (Berl) 96: 142-144.
17. Gardner, EL, Vorel, SR (1998) Cannabinoid transmission and reward-related events. Neurobiol Dis 5: 502-533.
18. Genn, RF, Tucci, S., Marco, EM, Viveros, MP, File, SE (2004) Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test. Pharmacol Biochem Behav 77: 567-573.
19. Giuliani, D., Ferrari, F., Ottani, A. (2000) The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress. Pharmacol Res 41: 47-53.
20. Goeders, NE (2002) Stress and cocaine addiction. J Pharmacol Exp Ther 301: 785-789.
21. Gouirand, AM, Matuszewich, L. (2005) The effects of chronic unpredictable stress on male rats in the water maze. Physiol Behav 86: 21-31.
22. Green, B., Kavanagh, D., Young, R. (2003) Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 22: 453-460.
23. Haile, CN, GrandPre, T., Kosten, TA (2001) Chronic unpredictable stress, but not chronic predictable stress, enhances the sensitivity to the behavioral effects of cocaine in rats. Psychopharmacology (Berl) 154: 213-220.
24. Hajos, N., Freund, TF (2002) Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem Phys Lipids 121: 73-82.
25. Haller, J., Bakos, N., Szirmay, M., Ledent, C., Freund, TF (2002) The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci 16: 1395-1398.
26. Haller, J., Varga, B., Ledent, C., Freund, TF (2004) CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol 15: 299-304.
27. Herman, JP, Stinus, L., Le Moal, M. (1984) Repeated stress increases locomotor response to amphetamine. Psychopharmacology (Berl) 84: 431-435.
28. Hill, MN, Gorzalka, BB (2004) Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress. Eur J Pharmacol 499: 291-295.
29. Hill, MN, Patel, S., Carrier, EJ, Rademacher, DJ, Ormerod, BK, Hillard, CJ, et al. (2005) Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 30: 508-515.
30. Hogg, S. (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54: 21-30.
31. Hollister, LE, Overall, JE (1975) Dimensions of marihuana experience. Drug Alcohol Depend 1: 155-164.
32. Isbell, H., Gorodetzsky, CW, Jasinski, D., Claussen, U., von Spulak, F., Korte, F. (1967) Effects of (-)delta-9-trans-tetrahydrocannabinol in man. Psychopharmacologia 11: 184-188.
33. Kornetsky, C. (1985) Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria. NIDA Res Monogr 62: 30-50.
34. Kucharski, LT, Williams, JE, Kornetsky, C. (1983) The effects of levonantradol on rewarding brain stimulation thresholds in the rat. Pharmacol Biochem Behav 19: 149-151.
35. Lepore, M., Liu, X., Savage, V., Matalon, D., Gardner, EL (1996) Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. Life Sci 58: PL365 - PL372.
36. Liebman, JM (1983) Discriminating between reward and performance: a critical review of intracranial self-stimulation methodology. Neurosci Biobehav Rev 7: 45-72.
37. Lin, D., Bruijnzeel, AW, Schmidt, P., Markou, A. (2002) Exposure to chronic mild stress alters thresholds for lateral hypothalamic stimulation reward and subsequent responsiveness to amphetamine. Neuroscience 114: 925-933.
38. Lister, RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92: 180-185.
39. Marco, EM, Perez-Alvarez, L., Borcel, E., Rubio, M., Guaza, C., Ambrosio, E., et al. (2004) Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. Behav Pharmacol 15: 21-27.
40. Marin, S., Marco, E., Biscaia, M., Fernandez, B., Rubio, M., Guaza, C., et al. (2003) Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats. Pharmacol Biochem Behav 74: 649-656.
41. Markou, A., Koob, GF (1992) Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 51: 111-119.
42. Martin, M., Ledent, C., Parmentier, M., Maldonado, R., Valverde, O. (2002) Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 159: 379-387.
43. McGregor, IS, Dastur, FN, McLellan, RA, Brown, RE (1996) Cannabinoid modulation of rat pup ultrasonic vocalizations. Eur J Pharmacol 313: 43-49.
44. Miczek, KA, Mutschler, NH (1996) Activational effects of social stress on IV cocaine self-administration in rats. Psychopharmacology (Berl) 128: 256-264.
45. Miliaressis, E., Rompre, PP, Laviolette, P., Philippe, L., Coulombe, D. (1986) The curve-shift paradigm in self-stimulation. Physiol Behav 37: 85-91.
46. Moreau, JL, Jenck, F., Martin, JR, Mortas, P., Haefely, WE (1992) Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur Neuropsychopharmacol 2: 43-49.
47. Moreau, JL, Scherschlicht, R., Jenck, F., Martin, JR (1995) Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment. Behav Pharmacol 6: 682-687.
48. Moreira, FA, Lutz, B. (2008) The endocannabinoid system: emotion, learning and addiction. Addict Biol 13: 196-212.
49. Nielsen, CK, Arnt, J., Sanchez, C. (2000) Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and interindividual differences. Behav Brain Res 107: 21-33.
50. Onaivi, ES, Green, MR, Martin, BR (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253: 1002-1009.
51. Ortiz, J., Fitzgerald, LW, Lane, S., Terwilliger, R., Nestler, EJ (1996) Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacology 14: 443-452.
52. Panagis, G., Vlachou, S., Nomikos, GG (2008) Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. Curr Drug Abuse Rev 1: 350-374.
53. Patel, S., Hillard, CJ (2006) Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 318: 304-311.
54. Paxinos, G., Watson, C. (2007) The rat brain in stereotaxic coordinates, sixth ed. Elsevier Amsterdam.
55. Pothion, S., Bizot, JC, Trovero, F., Belzung, C. (2004) Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 155: 135-146.
56. Rodgers, RJ, Evans, PM, Murphy, A. (2005) Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice. Behav Pharmacol 16: 405-413.
57. Rubino, T., Sala, M., Vigano, D., Braida, D., Castiglioni, C., Limonta, V., et al. (2007) Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats. Neuropsychopharmacology 32: 2036-2045.
58. Rutkowska, M., Jamontt, J., Gliniak, H. (2006) Effects of cannabinoids on the anxiety-like response in mice. Pharmacol Rep 58: 200-206.
59. Schramm-Sapyta, NL, Cha, YM, Chaudhry, S., Wilson, WA, Swartzwelder, HS, Kuhn, CM (2007) Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. Psychopharmacology (Berl) 191: 867-877.
60. Stark, P., Dews, PB (1980) Cannabinoids. I. Behavioral effects. J Pharmacol Exp Ther 214: 124-130.
61. Tzavara, ET, Wade, M., Nomikos, GG (2003) Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. J Neurosci 23: 9374-9384.
62. Valjent, E., Mitchell, JM, Besson, MJ, Caboche, J., Maldonado, R. (2002) Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135: 564-578.
63. Valverde, O. (2005) Participation of the cannabinoid system in the regulation of emotional-like behaviour. Curr Pharm Des 11: 3421-3429.
64. Viveros, MP, Marco, EM, File, SE (2005) Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav 81: 331-342.
65. Vlachou, S., Nomikos, GG, Panagis, G. (2003) WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation. Behav Brain Res 141: 215-222.
66. Vlachou, S., Nomikos, GG, Panagis, G. (2005) CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat. Psychopharmacology (Berl) 179: 498-508.
67. Vlachou, S., Nomikos, GG, Panagis, G. (2006) Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. Psychopharmacology (Berl) 188: 293-305.
68. Vlachou, S., Nomikos, GG, Stephens, DN, Panagis, G. (2007) Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents. Behav Pharmacol 18: 311-319.
69. Vlachou, S., Stamatopoulou, F., Nomikos, GG, Panagis, G. (2008) Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine. Int J Neuropsychopharmacol 11: 905-923.
70. Will, MJ, Watkins, LR, Maier, SF (1998) Uncontrollable stress potentiates morphinegs rewarding properties. Pharmacol Biochem Behav 60: 655-664.
71. Willner, P., Moreau, JL, Nielsen, CK, Papp, M., Sluzewska, A. (1996) Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiol Behav 60: 129-134.
72. Wise, RA (1996) Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19: 319-340.
73. Wise, RA (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend 51: 13-22.
74. Witkin, JM, Tzavara, ET, Nomikos, GG (2005) A role for cannabinoid CB1 receptors in mood and anxiety disorders. Behav Pharmacol 16: 315-331.